We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Medicure announced the United States Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single dose vial (SNP)......